Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 84

1.

Fangchinoline, a Bisbenzylisoquinoline Alkaloid can Modulate Cytokine-Impelled Apoptosis via the Dual Regulation of NF-κB and AP-1 Pathways.

Jung YY, Shanmugam MK, Chinnathambi A, Alharbi SA, Shair OHM, Um JY, Sethi G, Ahn KS.

Molecules. 2019 Aug 28;24(17). pii: E3127. doi: 10.3390/molecules24173127.

2.

Functional interplay between YY1 and CARM1 promotes oral carcinogenesis.

Behera AK, Kumar M, Shanmugam MK, Bhattacharya A, Rao VJ, Bhat A, Vasudevan M, Gopinath KS, Mohiyuddin A, Chatterjee A, Sethi G, Kundu TK.

Oncotarget. 2019 Jun 4;10(38):3709-3724. doi: 10.18632/oncotarget.26984. eCollection 2019 Jun 4.

3.

Focus on Formononetin: Anticancer Potential and Molecular Targets.

Ong SKL, Shanmugam MK, Fan L, Fraser SE, Arfuso F, Ahn KS, Sethi G, Bishayee A.

Cancers (Basel). 2019 May 1;11(5). pii: E611. doi: 10.3390/cancers11050611. Review.

4.

Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets.

Banik K, Ranaware AM, Deshpande V, Nalawade SP, Padmavathi G, Bordoloi D, Sailo BL, Shanmugam MK, Fan L, Arfuso F, Sethi G, Kunnumakkara AB.

Pharmacol Res. 2019 Jun;144:192-209. doi: 10.1016/j.phrs.2019.04.004. Epub 2019 Apr 17. Review.

PMID:
31002949
5.

Role of Natural Products in Modulating Histone Deacetylases in Cancer.

Merarchi M, Sethi G, Shanmugam MK, Fan L, Arfuso F, Ahn KS.

Molecules. 2019 Mar 16;24(6). pii: E1047. doi: 10.3390/molecules24061047. Review.

6.

Targeting autophagy using natural compounds for cancer prevention and therapy.

Deng S, Shanmugam MK, Kumar AP, Yap CT, Sethi G, Bishayee A.

Cancer. 2019 Apr 15;125(8):1228-1246. doi: 10.1002/cncr.31978. Epub 2019 Feb 12. Review.

PMID:
30748003
7.

Oxymatrine Attenuates Tumor Growth and Deactivates STAT5 Signaling in a Lung Cancer Xenograft Model.

Jung YY, Shanmugam MK, Narula AS, Kim C, Lee JH, Namjoshi OA, Blough BE, Sethi G, Ahn KS.

Cancers (Basel). 2019 Jan 7;11(1). pii: E49. doi: 10.3390/cancers11010049.

8.

Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling Axis.

Shanmugam MK, Ahn KS, Hsu A, Woo CC, Yuan Y, Tan KHB, Chinnathambi A, Alahmadi TA, Alharbi SA, Koh APF, Arfuso F, Huang RY, Lim LHK, Sethi G, Kumar AP.

Front Pharmacol. 2018 Dec 4;9:1294. doi: 10.3389/fphar.2018.01294. eCollection 2018.

9.

N-Substituted Pyrido-1,4-Oxazin-3-Ones Induce Apoptosis of Hepatocellular Carcinoma Cells by Targeting NF-κB Signaling Pathway.

Mohan CD, Bharathkumar H, Dukanya, Rangappa S, Shanmugam MK, Chinnathambi A, Alharbi SA, Alahmadi TA, Bhattacharjee A, Lobie PE, Deivasigamani A, Hui KM, Sethi G, Basappa, Rangappa KS, Kumar AP.

Front Pharmacol. 2018 Nov 5;9:1125. doi: 10.3389/fphar.2018.01125. eCollection 2018.

10.

Oleuropein induces apoptosis via abrogating NF-κB activation cascade in estrogen receptor-negative breast cancer cells.

Liu L, Ahn KS, Shanmugam MK, Wang H, Shen H, Arfuso F, Chinnathambi A, Alharbi SA, Chang Y, Sethi G, Tang FR.

J Cell Biochem. 2019 Mar;120(3):4504-4513. doi: 10.1002/jcb.27738. Epub 2018 Sep 27.

PMID:
30260018
11.

Evidence for the Involvement of the Master Transcription Factor NF-κB in Cancer Initiation and Progression.

Puar YR, Shanmugam MK, Fan L, Arfuso F, Sethi G, Tergaonkar V.

Biomedicines. 2018 Jul 27;6(3). pii: E82. doi: 10.3390/biomedicines6030082. Review.

12.

Role of RNF20 in cancer development and progression - a comprehensive review.

Sethi G, Shanmugam MK, Arfuso F, Kumar AP.

Biosci Rep. 2018 Jul 12;38(4). pii: BSR20171287. doi: 10.1042/BSR20171287. Print 2018 Aug 31. Review.

13.

Modulation of diverse oncogenic transcription factors by thymoquinone, an essential oil compound isolated from the seeds of Nigella sativa Linn.

Shanmugam MK, Arfuso F, Kumar AP, Wang L, Goh BC, Ahn KS, Bishayee A, Sethi G.

Pharmacol Res. 2018 Jul;133:213-214. doi: 10.1016/j.phrs.2018.05.004. Epub 2018 May 21. No abstract available.

PMID:
29792914
14.

Pro-Apoptotic and Anti-Cancer Properties of Diosgenin: A Comprehensive and Critical Review.

Sethi G, Shanmugam MK, Warrier S, Merarchi M, Arfuso F, Kumar AP, Bishayee A.

Nutrients. 2018 May 19;10(5). pii: E645. doi: 10.3390/nu10050645. Review.

15.

Celastrol Attenuates the Invasion and Migration and Augments the Anticancer Effects of Bortezomib in a Xenograft Mouse Model of Multiple Myeloma.

Shanmugam MK, Ahn KS, Lee JH, Kannaiyan R, Mustafa N, Manu KA, Siveen KS, Sethi G, Chng WJ, Kumar AP.

Front Pharmacol. 2018 May 3;9:365. doi: 10.3389/fphar.2018.00365. eCollection 2018.

16.

Potential role of genipin in cancer therapy.

Shanmugam MK, Shen H, Tang FR, Arfuso F, Rajesh M, Wang L, Kumar AP, Bian J, Goh BC, Bishayee A, Sethi G.

Pharmacol Res. 2018 Jul;133:195-200. doi: 10.1016/j.phrs.2018.05.007. Epub 2018 May 24. Review.

PMID:
29758279
17.

Correction: Role of novel histone modifications in cancer.

Shanmugam MK, Arfuso F, Arumugam S, Chinnathambi A, Bian J, Warrier S, Wang LZ, Kumar AP, Ahn KS, Sethi G, Lakshmanan M.

Oncotarget. 2018 Apr 10;9(27):19460. doi: 10.18632/oncotarget.25152. eCollection 2018 Apr 10.

18.

Novel 1,3,4-Oxadiazole Induces Anticancer Activity by Targeting NF-κB in Hepatocellular Carcinoma Cells.

Mohan CD, Anilkumar NC, Rangappa S, Shanmugam MK, Mishra S, Chinnathambi A, Alharbi SA, Bhattacharjee A, Sethi G, Kumar AP, Basappa, Rangappa KS.

Front Oncol. 2018 Mar 19;8:42. doi: 10.3389/fonc.2018.00042. eCollection 2018.

19.

Role of novel histone modifications in cancer.

Shanmugam MK, Arfuso F, Arumugam S, Chinnathambi A, Jinsong B, Warrier S, Wang LZ, Kumar AP, Ahn KS, Sethi G, Lakshmanan M.

Oncotarget. 2017 Dec 17;9(13):11414-11426. doi: 10.18632/oncotarget.23356. eCollection 2018 Feb 16. Review. Erratum in: Oncotarget. 2018 Apr 10;9(27):19460.

20.

The Application of Embelin for Cancer Prevention and Therapy.

Ko JH, Lee SG, Yang WM, Um JY, Sethi G, Mishra S, Shanmugam MK, Ahn KS.

Molecules. 2018 Mar 9;23(3). pii: E621. doi: 10.3390/molecules23030621. Review.

Supplemental Content

Loading ...
Support Center